Dr. Reddy's Laboratories will acquire select divisions of Wockhardt Limited's branded generics business in India, Nepal, Sri Lanka, Bhutan and Maldives.
Dr. Reddy's will acquire 62 brands across an array of specialties including neurology, dermatology, gastroenterology and pain management. The company will acquire all assets, including the sales and marketing teams and a manufacturing plant. Dr. Reddy's expects the transaction to close in the first quarter of the 2020 fiscal year.